China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Optimization and Application Research on Reperfusion Therapy for Acute Ischemic Stroke under National Quality Control Objectives'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136685

Registration Time: 2026/11/13

Type: Interventional study

Primary Sponsor: Meishan City Peoples Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=352697

Published by HT Digital Content Services with permission from Health Daily Digest....